Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
Abstract Indocyanine green (ICG) is a diagnostic dye commonly used in medical imaging and liver function monitoring. Given its widespread use, there is a need for detailed evaluations of its adverse drug reactions in real-world settings. As the comprehensive overview of its safety profile is very li...
        Saved in:
      
    
          | Main Authors: | Yan Jiao, Yahui Liu, Meng Jin | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Nature Portfolio
    
        2024-12-01 | 
| Series: | Scientific Reports | 
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-81903-z | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database        
                          
 by: Zhao YC, et al.
 Published: (2024-11-01)
- 
                
                    Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database        
                          
 by: Runan Fang, et al.
 Published: (2024-11-01)
- 
                
                    Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system        
                          
 by: Yanjun Lu, et al.
 Published: (2024-12-01)
- 
                
                    Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database        
                          
 by: Qun Li, et al.
 Published: (2025-02-01)
- 
                
                    Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database        
                          
 by: Peiyang Cao, et al.
 Published: (2025-01-01)
 
       